Les entreprises actives sur le marché du diagnostic médical en France
Abbot, AbilyCare, Acobiom, AgenT, Agoranov, Alcediag, Alcen, Algoscope, Alven, Anapix Medical, Apneal, Aprium Pharmacie, Arbevel Life Science Crossover, Artificial Insight, Avicenna.ai, Azmed, BabyProgress, BforCure, BIC Montpellier, Bio Logbook, Biogen, BioMAdvanced Diagnostics, bioMérieux, Bio-Rad, BioSerenity, BNP Paribas Développement, BrainTale, Caerus Medical , Cardiologs, Chanel, Chipiron, Cibiltech, CIC, Clarifai, Clarins, Clin’S MD, Clin’s MD, CM-CIC Innovation, Créalia Occitanie, Crédit Agricole, D&C Consultants, Damae Medical, Dassault Systèmes, Datexim, Depist&Vous, Depist&Vous, Di4 Diag, Diag2Tec, Diagnoly, Diagnostic Medical Systems, DreamQuark, Dyn’r, Elaia, eMyoSound, En Carta Diagnostics, Endodiag, EpiLAB, Eurobio Scientific, Eurofins, Fly Ventures, Fujifilm, GE Healthcare, Gilde Healthcare, Gleamer, Hera-MI, Holnest, ID Solutions, Idinvest, Idinvest Partners, Imageens, Impulse, ImVitro, Incepto, Incub’Alliance, Innovative Diagnostics, Irdi Capital Investissement, Isai, i-Virtual, Karl Storz, Keymaging, Kima Ventures, Kreizig, Kurma Partners, Lavorel Medicare, LBO France, LDV Capital, Lightstone Ventures, Luxia Scientific, LVMH, M2S, MagIA diagnostics, Majycc eSanté, Matmut, Medical Intelligence Service, Medipath, Mérieux Equity Partners, Milvue, Mindpulse, MMC, Nahibu, Nemo Health, Neolys Diagnostics, Neurocort, NG Biotech, Nouveal, NovaGrey, Nurea, Omnes, OncoMeca , Orange Healthcare, Orasis Eye Analytics & Rehabilitation, Paris&Co, PariSanté Campus, PathInvest, Pfizer Healthcare Lab, Philips, Pixience, Pixyl, Precision Genetics, Predilife, Prevent2Care Lab, Primaa, ProductLife Group, Quantiq.IO, Qwanteus, Raidium, RebrAin, Relais Thalasso Île de Ré, Roche, SeqOne Genomics, Sibius, Silab, Sodero Gestion, Sonup, SquareMind, Stago, Stilla Technologies, Superbranche, Synlab, TheraPanacea, Therapixel, Therinvest, Tiny VC, Traaser, Vensena Capital, VitaDX, Volta Medical, WeDiagnostix, Wedogood, Wiseed, WitMonki, Xpath, Zoi.